BioAffinity Profit Margin from 2010 to 2025

BIAFW Stock  USD 0.60  0.01  1.64%   
BioAffinity Technologies Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to -2.96 in 2025.
Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 301.4 K, Interest Expense of 40.6 K or Gross Profit of 955.9 K, as well as many indicators such as Price To Sales Ratio of 5.55, Dividend Yield of 0.0 or PTB Ratio of 2.5. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
  
Check out the analysis of BioAffinity Technologies Correlation against competitors.

Latest BioAffinity Technologies' Profit Margin Growth Pattern

Below is the plot of the Net Profit Margin of bioAffinity Technologies Warrant over the last few years. It is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. BioAffinity Technologies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.19) %10 Years Trend
Slightly volatile
   Net Profit Margin   
       Timeline  

BioAffinity Profit Margin Regression Statistics

Arithmetic Mean(1,380)
Geometric Mean516.26
Coefficient Of Variation(49.51)
Mean Deviation516.37
Median(1,698)
Standard Deviation683.17
Sample Variance466,724
Range1.7K
R-Value0.68
Mean Square Error270,619
R-Squared0.46
Significance0
Slope97.20
Total Sum of Squares7M

BioAffinity Profit Margin History

2025 -2.96
2024 -2.82
2023 -3.13

Other Fundumenentals of BioAffinity Technologies

BioAffinity Technologies Profit Margin component correlations

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Profit Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.81)(2.95)
Operating Profit Margin(2.83)(2.98)
Net Loss(2.82)(2.96)
Gross Profit Margin 0.36  0.67 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.